COMMUNIQUÉS West-GlobeNewswire

AzurRx BioPharma to Present at the Rodman & Renshaw 20th Annual Global Investment Conference on September 5th

28/08/2018 - 14:30

BROOKLYN, N.Y., Aug. 28, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]

Yield10 Bioscience to Present at the 20th Annual Rodman and Renshaw Global Investment Conference in New York City September 4-6, 2018

28/08/2018 - 14:30

WOBURN, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a company focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security [...]

Hemispherx Releases Recently Manufactured Ampligen for Pancreatic Cancer Early Access Program in the Netherlands to Fill Stock Order

28/08/2018 - 14:30

ORLANDO, Fla., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) announced today that the new Ampligen batch manufactured earlier this year is now released for patients' use in the [...]

Onconova Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference in New York City

28/08/2018 - 14:30

NEWTOWN, Pa., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary [...]

ChemoCentryx to Present at Two Upcoming Investor Conferences

28/08/2018 - 14:30

MOUNTAIN VIEW, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two upcoming investor [...]

Cytokinetics Awards Inaugural Communications Fellowship To The ALS Association Golden West Chapter

28/08/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that The ALS Association Golden West Chapter is the inaugural recipient of the Cytokinetics [...]

Viveve to Present at 20th Annual Rodman & Renshaw Global Investment Conference

28/08/2018 - 14:28

ENGLEWOOD, Colo., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. ("Viveve") (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive [...]

Avid Bioservices to Exhibit at the 2018 BioProcess International Conference & Exhibition

28/08/2018 - 14:05

-- Corporate Booth to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Highlighting Immediately Available 2,000-Liter Scale Bioreactor Capacity -- TUSTIN, Calif., Aug. 28, 2018 [...]

Sirona Biochem Receives $500,000 USD Milestone Payment from Wanbang Biopharmaceuticals

28/08/2018 - 14:00

VANCOUVER, British Columbia, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (Xetra: ZSB) (the “ Company ”) announced that it has received the $500,000 USD milestone payment from partner [...]

Medical City Plano, a HCA Healthcare Facility, Adopts iCAD’s Xoft Electronic Brachytherapy System for Treatment of Early-Stage Breast Cancer

28/08/2018 - 14:00

Leading center becomes first in Texas to offer intraoperative radiation therapy with the advanced Xoft System to enhance patient care NASHUA, N.H. and PLANO, Texas, Aug. 28, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc . (NASDAQ [...]

Nemaura Medical Strengthens Manufacturing Team in Preparation for SugarBEAT® Commercial Launch.

28/08/2018 - 14:00

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device for use by persons with diabetes and pre-diabetics today announced [...]

AVROBIO, Inc. to Present at Upcoming Investor Conferences

28/08/2018 - 14:00

CAMBRIDGE, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc . (NASDAQ:AVRO) (the “Company”), a Phase 2 clinical stage gene therapy company focused on developing potentially curative lentiviral-based gene therapies [...]

OPKO Health’s BioReference Laboratories to Participate in the National Cancer Institute NCI-MATCH (Molecular Analysis for Therapy Choice) Phase II Clinical Trial

28/08/2018 - 14:00

MIAMI, Aug. 28, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that BioReference Laboratories, Inc. (BRL), an OPKO Health company and the third largest clinical laboratory in the United States [...]

Progressive Care Inc. Earns International Media Coverage in Top Industry Outlets on Its Healthcare Technology Expertise

28/08/2018 - 14:00

MIAMI, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that Chief Executive Officer S. Parikh Mars has earned [...]

Immunomedics Announces Participation in Upcoming Healthcare Conferences

28/08/2018 - 14:00

MORRIS PLAINS, N.J., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]

VBI Vaccines to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

28/08/2018 - 14:00

CAMBRIDGE, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ:VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today [...]

Aeglea BioTherapeutics to Present at 2018 Wells Fargo Healthcare Conference

28/08/2018 - 14:00

Company to Webcast Presentation on Wednesday, September 5 at 10:50 am ET AUSTIN, Texas, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that designs [...]

Spero Therapeutics to Present New Data for SPR994 and SPR206 at ESCMID/ASM 2018 Conference

28/08/2018 - 14:00

Highlights include eleven presentations covering SPR994’s pharmacokinetics and pharmacodynamics, SPR206’s broad spectrum of activity and favorable toxicology, and urinary tract infection epidemiology CAMBRIDGE, Mass., [...]

Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 20th Annual Global Investment Conference on Wednesday, September 5, 2018

28/08/2018 - 13:50

FRAMINGHAM, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]